Brain β-amyloid links the association of change in BMI with cognitive decline in community-dwelling older adults.

BACKGROUND We tested the hypothesis that indices of AD and related dementia (ADRD) pathologies may explain associations between change in BMI and cognitive decline in old age. METHODS We used data from 436 older decedents participating in a prospective longitudinal cohort study who had undergone annual cognitive and BMI assessments and postmortem collection of indices of twelve brain pathologies. We identified ADRD brain pathologies associated with BMI range, a previously published metric of change in BMI. We employed sigmoidal mixed-effect models of cognitive decline to examine the associations of change in BMI and cognitive decline with and without terms for ADRD brain pathologies. RESULTS Average age at baseline was 78.6 years, SD=6.5 years with 64% female. On average nine cognitive assessments were obtained with average age at death 88.4 years (SD=6.2 years). Change in BMI as measured by BMI range was associated with cognitive decline (θ2=0.260). β-amyloid, hippocampal sclerosis, and substantia nigra neuronal loss were associated with BMI range. β-amyloid strongly attenuated the association of BMI range with cognitive decline. Hippocampal sclerosis showed only partial attenuation of the association of BMI range and cognitive decline and nigral neuronal loss did not attenuate this association. CONCLUSION Changes in BMI and cognitive decline in older adults may be affected by similar mechanisms underlying the accumulation of brain pathologies like β-amyloid in aging brains. Elucidating the molecular mechanisms underlying these associations may provide novel targets for developing interventions that maintain brain health and metabolic homeostasis in old age.